Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 7/14/2014
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / SYR|
Administered by: Other Purchased by: Other
Symptoms: Electrocardiogram normal, Endometriosis, Fatigue, Hypertension, Hypothyroidism, Tachycardia, Blood test normal, Activities of daily living impaired
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: GARDASIL
Diagnostic Lab Data: Blood test, inflammatory values: normal; Electrocardiogram, normal
CDC 'Split Type': WAES1403DEU006601
Write-up:Information has been received from Sanofi Pasteur MSD (report number DE-1577272925-E2014-02099) on 12-MAR-2014. Case was received from a healthcare professional on 07-Mar-2014. Case is medically confirmed. An about 15 year-old female patient received a third dose of GARDASIL (lot-no., injection route and site not reported) on an unspecified date in 2009. Mid of 2012, at the age of about 18 years, she developed tachycardia, arterial hypertension, hypothyroidism and endometriosis. She also felt exhausted. ECG and inflammatory values showed normal results, myocarditis as other cardiac diseases were ruled out. She was medicated with beta-blockers (not otherwise specified), BELLA HEXAL and unspecified thyroid drugs. She also received psychotherapy. Due to exhaustion, the patient was only able to work for four hours per day. At the time of reporting she had not recovered. According to the reporter, the events were not related to vaccination. Patient received two doses of GARDASIL on unspecified dates, toleration was not reported. Upon medical judgement the company assessed the case as serious due to disability (not able to work normally) and duration of the events.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166